Wednesday 3 October 2018

Cannabidiol

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.

http://sci-hub.tw/10.21873/anticanres.12924   (PDF download)
https://www.ncbi.nlm.nih.gov/pubmed/30275207  (abstract at pubmed)

RESULTS:

Clinical responses were seen in 92% of the 119 cases with solid tumours including a reduction in circulating tumour cells in many cases and in other cases, a reduction in tumour size, as shown by repeat scans. No side-effects of any kind were observed when using pharmaceutical grade synthetic cannabidiol.

4 comments:

  1. Thank youThis week In Portugal there was a short and shocking documentary of people desperate in need of CBD but it's illegal to produce and sell. There is a lot of discussion between infarmed that regulates the Portugal industry of pharmaceutical and do it your self.
    https://www.rtp.pt/play/p4231/linha-da-frente
    I read the article. Ty Stephan

    ReplyDelete
  2. Interesting that they mentioned using CBD with on and off schedule is beneficial. Anybody see this approach or other evidence somewhere else?
    Holly

    ReplyDelete
  3. Holly, I am also interested why they are using this pulsed approach. Has anyone come across the clinical evidence for this? Geraldine

    ReplyDelete